If you’ve been told there’s nothing you can do about dry AMD, there’s new hope. Valeda Light Therapy is an FDA-approved treatment that works differently than other options. Instead of just slowing progression, it’s designed to stimulate your retinal cells and help improve your vision. Quick sessions. Minimal side effects. Real results.
Valeda delivers a non-invasive, multiwavelength, light-based therapy that utilizes photobiomodulation (PBM) to treat dry age-related macular degeneration (AMD). This targeted treatment delivers specific wavelengths of light to the retina, stimulating cellular activity to improve vision and slow disease progression. Clinical studies have shown that Valeda can improve visual outcomes. Here’s the science:
Your retina has cells called photoreceptors. In dry AMD, these cells gradually break down, causing vision loss. Valeda’s light therapy is designed to energize these cells at the mitochondrial level, essentially giving them the boost they need to function better.
The result? Your retina may work more efficiently, potentially improving your vision and reducing drusen (the protein deposits that accumulate in dry AMD).
What makes it different:
At the initial assessment, a routine retinal examination with imaging is performed to verify that you are suitable for treatment. Follow-up retinal examinations with imaging will occur following your last treatment in each cycle.
The treatment is safe, non-invasive, and generally pain free. There is no down-time required following treatment.
A follow-up retinal examination with imaging is performed after your last treatment in each cycle.
Session Details:
Treatment Schedule: